ZA989665B - The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes. - Google Patents

The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.

Info

Publication number
ZA989665B
ZA989665B ZA9809665A ZA989665A ZA989665B ZA 989665 B ZA989665 B ZA 989665B ZA 9809665 A ZA9809665 A ZA 9809665A ZA 989665 A ZA989665 A ZA 989665A ZA 989665 B ZA989665 B ZA 989665B
Authority
ZA
South Africa
Prior art keywords
glycosaminoglycans
diabetes
pharmaceutical preparations
disorders associated
eye disorders
Prior art date
Application number
ZA9809665A
Inventor
F J Van Der Woude
Dieter Herr Volker Laux
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA989665B publication Critical patent/ZA989665B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
ZA9809665A 1997-10-24 1998-10-23 The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes. ZA989665B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (en) 1997-10-24 1997-10-24 Compositions for treating diabetic retinopathy

Publications (1)

Publication Number Publication Date
ZA989665B true ZA989665B (en) 2000-04-25

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9809665A ZA989665B (en) 1997-10-24 1998-10-23 The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.

Country Status (13)

Country Link
EP (1) EP1047434A2 (en)
JP (1) JP2001520987A (en)
KR (1) KR20010024550A (en)
CN (1) CN1277554A (en)
AU (1) AU749673B2 (en)
BR (1) BR9813098A (en)
CA (1) CA2306379A1 (en)
DE (1) DE19747195A1 (en)
HU (1) HUP0004647A3 (en)
IL (1) IL135171A0 (en)
NO (1) NO20001895D0 (en)
WO (1) WO1999021538A2 (en)
ZA (1) ZA989665B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (en) * 1999-07-08 2001-01-08 Bidifarm S R L USE OF PROTEOGYLICAN OLIGOSACCHARIDIC METABOLITES AS MAKER IN BIOLOGICAL FLUIDS FOR DIAGNOSIS OF BIABET AND PATHOLOGICAL COMPLICATIONS C
CN101584704B (en) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 Medicinal application of medicinal salt or derivative of heparin and low molecular heparin
JPWO2011122321A1 (en) * 2010-03-29 2013-07-08 国立大学法人名古屋大学 Bioactivity inhibitors for heparin-binding proteins
CN107137421A (en) * 2017-05-25 2017-09-08 青岛市中心医院 Dextran sulfate is preparing the application in suppressing corneal vascularization medicine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (en) * 1986-04-17 1988-12-23 Sanofi Sa GLYCOSAMINOGLYCANS OF THE HEPARIN OR HEPARANE-SULPHATE TYPE WITH ACTIVITY ON CELL DIVISION AND DIFFERENTIATION, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS.
AU2139388A (en) * 1988-06-27 1990-01-23 Roland Reiner Glycosaminoglycane for the treatment of diabetic microangiopathy
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (en) * 1989-04-24 1990-11-20 Harvard College PROCESS FOR THE PREPARATION OF OLIGOSACARIDES OF LOW MOLECULAR WEIGHT DERIVED FROM HEPARIN OR DESPOLYMENED HEPARAN SULFATE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AU7520394A (en) * 1993-08-13 1995-03-14 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
EP0722326A4 (en) * 1993-10-07 1999-10-06 Glycomed Inc Highly sulfated maltooligosaccharides with heparin-like properties
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
AU9160498A (en) * 1997-07-28 1999-02-16 Rijksuniversiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy

Also Published As

Publication number Publication date
HUP0004647A3 (en) 2002-01-28
AU749673B2 (en) 2002-07-04
EP1047434A2 (en) 2000-11-02
NO20001895L (en) 2000-04-12
WO1999021538A2 (en) 1999-05-06
NO20001895D0 (en) 2000-04-12
DE19747195A1 (en) 1999-04-29
CA2306379A1 (en) 1999-05-06
JP2001520987A (en) 2001-11-06
HUP0004647A2 (en) 2001-05-28
CN1277554A (en) 2000-12-20
IL135171A0 (en) 2001-05-20
WO1999021538A3 (en) 1999-08-05
BR9813098A (en) 2000-08-15
KR20010024550A (en) 2001-03-26
AU1335599A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
EP0658111A4 (en) Methods for enhancing drug delivery with modified saponins.
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
ZA97976B (en) Uniform drug delivery theraphy.
AU2508597A (en) Drug for the treatment of tumours
HK1040980A1 (en) Biphenylsulfonylcyanamides,process for their preparation, and their use as medicament
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
EP0601909A3 (en) Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof.
HUP9601305A2 (en) Fluorine-containing benzoyl-guanidine derivatives, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
ZA989665B (en) The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.
HK1038510A1 (en) Use of neurotrophic factor stimulators for the treamtent of ophthalmic neurodegenerative diseases.
MXPA01003761A (en) Remedies for ocular diseases.
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
EP0968716A4 (en) Drugs for ameliorating ocular circulatory disorders
ZA932450B (en) Drugs for the treatment of diabetes
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
ZA93694B (en) Pharmaceutical treatments.
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
HUT76806A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents